Press Releases

Date Title and Summary
Toggle Summary 10-Year Data Shows Accuray CyberKnife® System Provides Long-Lasting Relief of the Excruciating Pain Caused by Trigeminal Neuralgia
Study Abstract Recognized as Best Clinical Abstract at 2022 Radiosurgical Society Meeting SUNNYVALE, Calif. , March 31, 2022 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that long-term follow-up data from a study of men and women with trigeminal neuralgia (TN) showed 72
Toggle Summary CARTI Selects Accuray CyberKnife® S7™ System to Increase Access to Advanced Cancer Care for Patients in Rural Communities Throughout Arkansas
CARTI is First in Arkansas to Treat Patients with World's Only Robotic Radiosurgery System SUNNYVALE, Calif. , March 8, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the CARTI medical care team in Little Rock, Arkansas has treated the first patients in the state
Toggle Summary NICE Endorses Radiosurgery Treatments for Trigeminal Neuralgia, Supporting Accuray CyberKnife® System Indications for Use
Robotic Radiosurgery System Provides Effective, Non-invasive Treatment Option for this Chronic Pain Condition, Typically Delivered in Just One Out-Patient Procedure SUNNYVALE, Calif. , Feb. 28, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the National Institute for
Toggle Summary Accuray to Participate in the Cowen 42nd Annual Health Care Conference
Company to Take Part in Fireside Chat Monday, March 7, 2022 at 9:50am PST / 12:50pm EST SUNNYVALE, Calif. , Feb. 24, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Cowen 42nd Annual Health Care Conference taking place March 7-9, 2022 .
Toggle Summary Largest Hospital in Queensland, Australia Acquires Multiple Accuray Radixact® Systems with the ClearRT™ Helical Fan-Beam kVCT Imaging and Synchrony® Technologies
- Royal Brisbane and Women's Hospital acquisition is intended to expand access to potentially life-saving radiotherapy treatments to more patients - Hospital was the first in Australia to invest in the TomoTherapy® helical radiotherapy delivery platform and is now the first to secure the latest
Toggle Summary Accuray TomoTherapy® Helical Radiotherapy System Helps Preserve Breast Cancer Patients' Long-term Heart and Lung Functionality
- Phase III, randomized controlled trial results highlight patient reported outcomes at 10 years'follow-up - TomoTherapy delivered hypofractionated radiotherapy was superior to conventional radiotherapy in maintaining patients' heart and lung functioning, enabling them to more easily perform daily
Toggle Summary Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
SUNNYVALE, Calif. , Feb. 7, 2022 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) announced today its participation in the virtual BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference , which takes place February 15-17, 2022 .
Toggle Summary Accuray Reports Fiscal 2022 Second Quarter Financial Results
Record Revenue For Second Quarter Fiscal 2022 SUNNYVALE, Calif. , Jan. 26, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter of fiscal 2022 ended December 31, 2021 .     Second Quarter Fiscal 2022 Summary Record net revenue of $116.3
Toggle Summary Accuray to Report Second Quarter Fiscal 2022 Financial Results on January 26, 2022
SUNNYVALE, Calif. , Jan. 12, 2022 /PRNewswire/ -- Accuray Incorporated  (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2022, ended December 31, 2021, after the market close on Wednesday, January 26, 2022. Management will host a conference call to review the
Toggle Summary Accuray CyberKnife® Robotic Radiosurgery System Receives Shonin Approval to Treat Trigeminal Neuralgia, a Chronic Pain Condition Affecting a Facial Nerve
- Trigeminal neuralgia, a persistent neurological disorder, is described by some patients as the most excruciating pain human beings can experience(1) - The approval expands global patient access to the CyberKnife System, an effective, non-invasive treatment alternative to surgery SUNNYVALE, Calif.

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at and on the SEC's website at